DelveInsight launched a new report on Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Insights, Epidemiology and Market Forecast 2030.
Neuromyelitis Optica spectrum disorder (NMOSD), also known as Devic disease, is a chronic disorder of the brain and spinal cord dominated by inflammation of the optic nerve (optic neuritis) and inflammation of the spinal cord (myelitis).
DelveInsight’s “Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Report 2030“ delivers an in-depth understanding of the Neuromyelitis Optica Spectrum Disorder (NMOSD), historical and forecasted epidemiology as well as the Neuromyelitis Optica Spectrum Disorder (NMOSD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Classically, it was felt to be a monophasic illness, consisting of episodes of inflammation of one or both optic nerves and the spinal cord over a short period (days or weeks) but, after the initial episode, no recurrence.
It is now recognized that most patients satisfying current criteria for NMOSD experience repeated attacks separated by periods of remission. The interval between attacks may be weeks, months, or years. In its early stages, NMOSD may be confused with multiple sclerosis (MS).
Request for free sample pages of the report: https://www.delveinsight.com/sample-request/neuromyelitis-optica-spectrum-disorder-nmosd-market
NMOSD can affect children as young as 3 years and adults as old as 90 years. The onset of NMOSD varies from childhood to adulthood, and the average age of onset is about 40.
NMOSD Treatment Options:
NMOSD Key pharma players involved:
The NMOSD market size shall grow during the forecast period owing to the launch of upcoming therapies and is expected to increase at a CAGR of XX during the study period.
Click here and download sample pages of the report.
Table of contents:
1 Key Insight2 Executive Summary of Neuromyelitis Optica Spectrum Disorder (NMOSD) market3 Neuromyelitis Optica Spectrum Disorder (NMOSD) market, Market Overview at a Glance4 Disease Background and Overview: Neuromyelitis Optica Spectrum Disorder (NMOSD) market,5 Case Reports6 Neuromyelitis Optica Spectrum Disorder (NMOSD) market, Epidemiology and Patient Population7 United States Epidemiology8 EU5 Epidemiology9 Japan Epidemiology10 Current Neuromyelitis Optica Spectrum Disorder (NMOSD) market, Treatment and Medical Practices11 Unmet needs12 Neuromyelitis Optica Spectrum Disorder (NMOSD) market, Marketed Drugs13 Neuromyelitis Optica Spectrum Disorder (NMOSD) market, Emerging Drugs14 Neuromyelitis Optica Spectrum Disorder (NMOSD) market, 7MM Market Analysis15 United States16 EU-5 countries: Market Outlook17 Japan Market Outlook18 Neuromyelitis Optica Spectrum Disorder (NMOSD) market, Market Drivers19 Neuromyelitis Optica Spectrum Disorder (NMOSD) market, Market Barriers20 SWOT Analysis21 Reimbursement and market access22 Appendix23 DelveInsight Capabilities24 Disclaimer25 About DelveInsight
Download report: https://www.delveinsight.com/report-store/neuromyelitis-optica-spectrum-disorder-nmosd-market
About DelveInsightDelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/